-$0.32 EPS Expected for Teladoc Health Inc (NYSE:TDOC) This Quarter

Wall Street analysts expect that Teladoc Health Inc (NYSE:TDOC) will announce ($0.32) earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Nine analysts have provided estimates for Teladoc Health’s earnings, with the highest EPS estimate coming in at ($0.23) and the lowest estimate coming in at ($0.40). Teladoc Health reported earnings per share of ($0.35) in the same quarter last year, which would suggest a positive year over year growth rate of 8.6%. The company is expected to announce its next quarterly earnings results on Wednesday, February 26th.

According to Zacks, analysts expect that Teladoc Health will report full-year earnings of ($1.43) per share for the current financial year, with EPS estimates ranging from ($1.47) to ($1.34). For the next fiscal year, analysts forecast that the firm will post earnings of ($1.14) per share, with EPS estimates ranging from ($1.41) to ($0.94). Zacks’ earnings per share calculations are a mean average based on a survey of sell-side research firms that that provide coverage for Teladoc Health.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Wednesday, October 30th. The health services provider reported ($0.28) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.40) by $0.12. Teladoc Health had a negative net margin of 20.15% and a negative return on equity of 11.23%. The business had revenue of $137.96 million for the quarter, compared to analysts’ expectations of $136.46 million. During the same quarter last year, the company earned ($0.34) EPS. The company’s revenue for the quarter was up 24.3% compared to the same quarter last year.

A number of analysts recently weighed in on the stock. ValuEngine cut shares of Teladoc Health from a “buy” rating to a “hold” rating in a report on Tuesday, December 10th. Stifel Nicolaus assumed coverage on shares of Teladoc Health in a report on Monday, November 25th. They issued a “hold” rating and a $83.00 price objective on the stock. Bank of America increased their price objective on shares of Teladoc Health from $90.00 to $106.00 and gave the stock a “neutral” rating in a report on Friday. UBS Group assumed coverage on shares of Teladoc Health in a report on Friday, January 10th. They issued a “neutral” rating and a $90.00 price objective on the stock. Finally, Guggenheim reaffirmed a “buy” rating and issued a $110.00 price objective (up previously from $90.00) on shares of Teladoc Health in a report on Tuesday, January 14th. Nine investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. Teladoc Health presently has a consensus rating of “Buy” and an average price target of $91.76.

In other Teladoc Health news, insider Lewis Levy sold 2,025 shares of the firm’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $84.00, for a total transaction of $170,100.00. Following the transaction, the insider now owns 5,655 shares of the company’s stock, valued at approximately $475,020. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CAO Gabriel R. Cappucci sold 9,569 shares of the firm’s stock in a transaction dated Thursday, October 31st. The shares were sold at an average price of $75.00, for a total transaction of $717,675.00. Following the transaction, the chief accounting officer now directly owns 10,798 shares in the company, valued at approximately $809,850. The disclosure for this sale can be found here. In the last three months, insiders have sold 68,099 shares of company stock worth $5,151,311. 3.95% of the stock is owned by corporate insiders.

A number of institutional investors have recently added to or reduced their stakes in TDOC. Torray LLC bought a new position in shares of Teladoc Health during the 3rd quarter valued at about $930,000. UBS Asset Management Americas Inc. boosted its position in shares of Teladoc Health by 16.6% during the 2nd quarter. UBS Asset Management Americas Inc. now owns 297,466 shares of the health services provider’s stock valued at $19,755,000 after purchasing an additional 42,387 shares in the last quarter. CNB Bank boosted its position in shares of Teladoc Health by 100.0% during the 3rd quarter. CNB Bank now owns 400 shares of the health services provider’s stock valued at $27,000 after purchasing an additional 200 shares in the last quarter. Symmetry Peak Management LLC bought a new position in shares of Teladoc Health during the 3rd quarter valued at about $237,000. Finally, First Trust Advisors LP boosted its position in shares of Teladoc Health by 151.2% during the 3rd quarter. First Trust Advisors LP now owns 69,876 shares of the health services provider’s stock valued at $4,732,000 after purchasing an additional 42,057 shares in the last quarter.

Shares of TDOC stock traded down $4.70 during trading hours on Friday, reaching $98.10. The stock had a trading volume of 1,320,336 shares, compared to its average volume of 1,197,320. The company has a debt-to-equity ratio of 0.44, a current ratio of 6.55 and a quick ratio of 6.55. Teladoc Health has a twelve month low of $48.57 and a twelve month high of $103.53. The firm has a 50-day simple moving average of $85.50 and a 200-day simple moving average of $73.63. The firm has a market capitalization of $7.44 billion, a PE ratio of -66.73 and a beta of 1.38.

About Teladoc Health

Teladoc Health, Inc provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Featured Story: Moving Average (MA)

Get a free copy of the Zacks research report on Teladoc Health (TDOC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.